Improving tests and treatments for peanut and tree nut allergies
Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nuts
This project looks at how specific peanut and tree nut proteins trigger allergic reactions to help children and adults with these food allergies.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-11163426 on NIH RePORTER |
What this research studies
If you have a peanut or tree nut allergy, researchers are focusing on the small proteins (called 2S albumins) that cause IgE antibody reactions. They use blood samples and sensitive lab tests like ELISA to map the exact amino acids and 3D-shaped peptide pieces that bind patient IgE. The team compares these protein pieces across different nuts to understand why some people react to multiple nuts. They aim to use those findings to create more accurate blood tests and to design molecules that could block or reduce allergic reactions.
Who could benefit from this research
Good fit: Children and adults with suspected or confirmed peanut or tree nut allergy, or those with unclear allergy test results, would be the most relevant candidates.
Not a fit: People who do not have peanut or tree nut allergies or who have non-IgE-mediated food sensitivities are unlikely to benefit.
Why it matters
Potential benefit: Could lead to more accurate diagnostics and new molecules that reduce or prevent allergic reactions to peanuts and tree nuts.
How similar studies have performed: Related approaches like early food introduction and oral immunotherapy with anti-IgE have helped some patients, but using 3D peptide mapping to make better diagnostics or blockers is relatively new.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Dreskin, Stephen C — University of Colorado Denver
- Study coordinator: Dreskin, Stephen C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.